Here is a question to Dr. Donald Schwartz about therapeutic ultrasound for glaucoma. In one of your papers, you wrote:
We hypothesized that the application of low-power and low-frequency focused ultrasound energy to the trabecular meshwork could result in the lowering of intraocular pressure by triggering a similar cytokine cascade to that triggered by SLT laser. To verify the hypothesis, we designed a prospective study.
What is the mechanism by which a cytokine cascade in the anterior chamber leads to long-term reduced intraocular pressure in glaucoma?
How long does the increased inflammation persist post-treatment in eyes treated by TUG?